LES LABORATOIRES BIOTECH : revenue, balance sheet and financial ratios

LES LABORATOIRES BIOTECH is a French company founded 10 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in PARIS (75016), this company of category PME shows in 2020 a revenue of 6.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - LES LABORATOIRES BIOTECH (SIREN 818576563)
Kennzahl 2024 2023 2022 2020 2019 2018 2017 2016
Umsatz N/C N/C N/C 6 635 244 € 12 246 398 € 5 910 503 € 1 993 873 € 169 733 €
Nettoergebnis 409 807 € -720 566 € 103 199 € 203 546 € 695 380 € 371 664 € 166 952 € 24 215 €
EBITDA N/C N/C N/C 271 521 € 1 201 221 € 507 859 € 224 220 € 28 491 €
Nettomarge N/C N/C N/C 3.1% 5.7% 6.3% 8.4% 14.3%

Umsatz und Gewinn- und Verlustrechnung

In 2024, LES LABORATOIRES BIOTECH generates positive net income of 410 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 24 k€ -> 410 k€.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

409 807 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at -3%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

-3.422%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

-5.541%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

19.5%

Entwicklung der Solvenzkennzahlen
LES LABORATOIRES BIOTECH

Positionnement sectoriel

Debt ratio
-3.42 2024
2022
2023
2024
Q1: 0.0
Méd: 4.27
Q3: 43.96
Excellent -26 pts über 3 Jahre

In 2024, the debt ratio of LES LABORATOIRES BIOTECH (-3.42) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-5.54% 2024
2022
2023
2024
Q1: 14.64%
Méd: 38.36%
Q3: 60.56%
Average

In 2024, the financial autonomy of LES LABORATOIRES BIOTECH (-5.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 86.11. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

86.115

Entwicklung der Liquiditätskennzahlen
LES LABORATOIRES BIOTECH

Positionnement sectoriel

Liquidity ratio
86.11 2024
2022
2023
2024
Q1: 132.74
Méd: 202.27
Q3: 325.9
Watch

In 2024, the liquidity ratio of LES LABORATOIRES BIOTECH (86.11) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operatives Working Capital (2024) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2024) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

0 j

Lieferantenverbindlichkeiten (2024) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

0 j

Lagerumschlag (2024) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
LES LABORATOIRES BIOTECH

Positionnement de LES LABORATOIRES BIOTECH dans son secteur

Vergleich mit der Branche Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Bewertungsschätzung

Based on 124 transactions of similar company sales (all years), the value of LES LABORATOIRES BIOTECH is estimated at 336 662 € (range 128 136€ - 1 229 450€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
124 transactions
128k€ 336k€ 1229k€
336 662 € Range: 128 136€ - 1 229 450€
NAF 5 all-time

Valuation method used

Net Income Multiple
409 807 € × 0.8x = 336 663 €
Range: 128 136€ - 1 229 450€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare LES LABORATOIRES BIOTECH with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about LES LABORATOIRES BIOTECH

What is the revenue of LES LABORATOIRES BIOTECH ?

The revenue of LES LABORATOIRES BIOTECH in 2020 is 6.6 M€.

Is LES LABORATOIRES BIOTECH profitable?

Yes, LES LABORATOIRES BIOTECH generated a net profit of 410 k€ in 2024.

Where is the headquarters of LES LABORATOIRES BIOTECH ?

The headquarters of LES LABORATOIRES BIOTECH is located in PARIS (75016), in the department Paris.

Where to find the tax return of LES LABORATOIRES BIOTECH ?

The tax return of LES LABORATOIRES BIOTECH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LES LABORATOIRES BIOTECH operate?

LES LABORATOIRES BIOTECH operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.